FrancophonIA/ELRC3.0 huggingface dataset:
English: Peripheral arteriopathy should be excluded by assessment of the pedal pulses or other techniques.
Slovenian: Osteomielitis ugotavljajte z rentgenskim pregledom, periferno arteriopatijo pa izključite z oceno stopalnih pulzov ali z drugimi tehnikami.
English: Becaplermin is produced by insertion of the gene for the B chain of human platelet derived growth factor into the yeast, Saccharomyces cerevisiae.
Slovenian: Bekaplermin izdelujejo z vstavljanjem gena za verigo B humanega rastnega faktorja iz trombocitov v kvasovko Saccharomyces cerevisiae.
English: • Do not apply pressure or walk on the ulcer during treatment.
Slovenian: • Med zdravljenjem na razjedo ne smete pritiskati ali hoditi po njej.
English: The displayed frequency categories use the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to <1/100); rare (≥1/10,000 to <1/1000); very rare (<1/10,000); not known (cannot be estimated from the available clinical trial data).
Slovenian: pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: REGRANEX is used to help the growth of normal tissue in order to heal skin ulcers.
Slovenian: Zdravilo REGRANEX se uporablja za pomoč pri rasti normalnih tkiv za boljše celjenje razjed.
English: • Infected skin ulcer (very common)
Slovenian: • okužbo razjede (zelo pogosto).
English: The biological activity of becaplermin includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair.
Slovenian: Med biološke učinke bekaplermina sodi tudi spodbujanje kemotaktičnega privabljanja in proliferacije celic, ki sodelujejo pri celjenju ran.
English: INFORMATION IN BRAILLE (CARTON ONLY) REGRANEX
Slovenian: PODATKI V BRAILLOVI PISAVI regranex
English: It is used with other good wound care measures to help with the healing of the ulcers.
Slovenian: Uporablja se skupaj z drugimi ukrepi pravilne oskrbe ran za pomoč pri celjenju razjed.
English: OUTER BOX/TUBE
Slovenian: PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ZUNANJA ŠKATLA/TUBA
English: • Your ulcer should be cleaned with salt solution or water.
Slovenian: • Razjedo morate očistiti s fiziološko raztopino ali z vodo.
English: In a preclinical study designed to determine the effects of PDGF on exposed bone, rats injected at the metatarsals with 3 or 10 μg/site (concentration of 30 or 100 μg/ml/site) of becaplermin every other day for 13 days displayed histological changes indicative of accelerated bone remodelling consisting of periosteal hyperplasia and subperiosteal bone resorption and exostosis.
Slovenian: V predklinični študiji, katere namen je bil ugotoviti učinke PDGF na izpostavljeno kost, so podganam injicirali bekaplermin v metatarzalne kosti v odmerku 3 ali 10 μg na posamezno mesto injiciranja (koncentracija 30 ali 100 μg/ml na mesto injiciranja), in sicer vsak drugi dan,13 dni.
English: Burning sensation1
Slovenian: Bolezni živčevja pekoč občutek1
English: • Do not touch the wound with the tip of the tube
Slovenian: • Z vrhom tube se ne smete dotakniti rane.
English: - The tube should be closed tightly after each use.
Slovenian: - Po vsaki uporabi tubo tesno zaprite.
English: If you are unsure, talk to your doctor or pharmacist before using REGRANEX.
Slovenian: Če ste negotovi, se pred uporabo zdravila REGRANEX posvetujte s svojim zdravnikom ali s farmacevtom.
English: Becaplermin is a human recombinant Platelet Derived Growth Factor (rhPDGF).
Slovenian: Bekaplermin je humani rekombinantni rastni faktor iz trombocitov (rhPDGF).
English: • Infections of the bone which may be seen as fever, severe pain, swelling and redness around the bone that is affected
Slovenian: • okužbe kosti, ki se kažejo s povišano telesno temperaturo, hudo bolečino, oteklino in rdečino ob prizadeti kosti.
English: • Only apply REGRANEX to the wound area.
Slovenian: • Zdravilo REGRANEX nanesite samo na razjedo.
English: The usual dose is one application once a day for a maximum of 20 weeks.
Slovenian: Običajni odmerek je en nanos gela na dan, največ 20 dni.
English: The bundled term burning sensation consists of the preferred terms burning sensation, skin burning sensation, and application site irritation, all of which referred specifically to burning at
Slovenian: Izraz pekoč občutek združuje izraze pekoč občutek, pekoč občutek na koži in draženje mesta aplikacije (ki se nanaša na pekoč občutek na mestu aplikacije).
English: Each gram contains E218 (methyl parahydroxybenzoate) 1.56 mg and E216 (propyl parahydroxybenzoate) 0.17 mg, see section 4.4.
Slovenian: En gram gela vsebuje 1,56 mg E218 (metilparahidroksibenzoat) in 0,17 mg E216 (propilparahidroksibenzoat), glejte poglavje 4.4.
English: REGRANEX should not be used continuously for more than 20 weeks.
Slovenian: Kdaj je treba prenehati z uporabo zdravila REGRANEX Zdravila REGRANEX ne smete neprekinjeno uporabljati dlje kot 20 tednov.
English: The site(s) of application should then be covered by a moist saline gauze dressing that maintains a moist wound-healing environment.
Slovenian: Mesto(a) nanosa gela potem prekrijte z mokrim obkladkom iz gaze, namočene v fiziološko raztopino, ki bo ohranjal vlažno okolje za boljše celjenje rane.
English: If you are unsure, check with your doctor or pharmacist
Slovenian: Če ste negotovi, se posvetujte z zdravnikom ali s farmacevtom.
English: - Hands should be washed thoroughly before applying REGRANEX.
Slovenian: - Pred nanašanjem zdravila REGRANEX si temeljito umijte roke.
English: REGRANEX should not be used in conjunction with occlusive dressings.
Slovenian: Zdravila REGRANEX ne smete uporabljati skupaj z okluzivnim povojem.
English: - Before each application, the ulcer should be gently rinsed with saline or water to remove residual gel.
Slovenian: - Pred vsakim nanosom gela ulkus previdno sperite s fiziološko raztopino ali vodo, da z njega odstranite preostali gel.
English: There are limited data on the effects of becaplermin overdose.
Slovenian: Podatkov o prekomernem odmerjanju bekaplermina je malo.
English: REGRANEX is a clear colourless to straw-coloured gel.
Slovenian: Zdravilo Regranex je prozoren, brezbarven do rumenkast gel.
English: Following 14 consecutive daily topical applications of REGRANEX, there was no consistent increase in plasma platelet-derived growth factor-BB concentrations above pre-treatment concentrations.
Slovenian: Po 14 dnevnem zaporednem nanašanju gela REGRANEX na razjede ni bilo enotnih podatkov o povečanju plazemskih koncentracij rastnega dejavnika iz trombocitov-BB v primerjavi s koncentracijami pred zdravljenjem.
English: Do not use REGRANEX after the expiry date, which is stated on the tube and the outer carton after EXP.
Slovenian: Zdravila REGRANEX ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na tubi in na škatli za oznako Uporabno do. Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: • You have infections of the bone which may be seen as fever, severe pain around the bone that is affected, swelling and redness of the joints
Slovenian: • imate okužbo kosti, ki se lahko kaže s povišano telesno temperaturo, hudo bolečino ob prizadeti kosti, oteklimi ali rdečimi sklepi,
English: Including the above-mentioned ADRs, the following table displays ADRs that have been reported with the use of REGRANEX from either clinical trial or postmarketing experiences.
Slovenian: V spodnji preglednici so, vključno z zgoraj omenjenimi, navedeni neželeni učinki, o katerih so poročali v kliničnih preskušanjih ali v redni klinični praksi.
English: Thus it helps the growth of normal tissue for healing.
Slovenian: Tako bekaplermin pomaga pri rasti normalnega tkiva, ki je potrebna za celjenje.
English: Marketing authorisation holder: JANSSEN-CILAG INTERNATIONAL NV Turnhoutseweg, 30
Slovenian: Imetnik dovoljenja za promet z zdravilom: JANSSEN-CILAG INTERNATIONAL NV Turnhoutseweg, 30
English: REGRANEX contains becaplermin, a recombinant human Platelet Derived Growth Factor-BB (rhPDGF-BB).
Slovenian: Zdravilo REGRANEX vsebuje bekaplermin, rekombinantni humani rastni faktor iz trombocitov-BB (rhPDGF-BB).
English: Efficacy has not been demonstrated for ulcers of baseline surface area > 5 cm2.
Slovenian: Pri ulkusih z začetno površino > 5 cm2 niso dokazali učinkovitosti zdravila.
English: • If you have any further questions, ask your doctor or your pharmacist.
Slovenian: - Če imate dodatna vprašanja, se posvetujte z zdravnikom ali s farmacevtom.
English: It is not known whether becaplermin is excreted in human milk.
Slovenian: Ni znano, ali se bekaplermin izloča v materino mleko pri človeku, zato zdravila REGRANEX pri dojenju ne smete uporabljati.
English: Good wound care measures include: • Your doctor or healthcare professional removing dead skin/debris from the wound whenever
Slovenian: • po potrebi zdravnik ali drug zdravstveni delavec odstrani mrtvo kožo/ostanke rane,
English: Prior to the use of REGRANEX, related underlying conditions such as osteomyelitis and peripheral arteriopathy should be excluded or treated if present.
Slovenian: Pred uporabo zdravila REGRANEX morate tudi bodisi izključiti ali pozdraviti morebitne druge sorodne osnovne bolezni, ki jih ima bolnik, kot na primer osteomielitis in periferno arteriopatijo.
English: A. MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE AUTHORISATION HOLDER (S) RESPONSIBLE FOR
Slovenian: A. IZDELOVALEC (IZDELOVALCI) BIOLOŠKE ZDRAVILNE UČINKOVINE
English: Therapy should be continued to the maximum of 20 weeks as long as healing progress is seen on periodic evaluations.
Slovenian: Če ob rednih kontrolnih pregledih opažate napredek pri celjenju ulkusa, lahko s terapijo nadaljujete do največ 20 tednov.
English: What REGRANEX contains
Slovenian: Kaj vsebuje zdravilo REGRANEX
English: Important information about possible allergies to some of the ingredients REGRANEX contains E218 (methyl parahydroxybenzoate) and E216 (propyl parahydroxybenzoate).
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila REGRANEX Zdravilo REGRANEX vsebuje E218 (metilparahidroksibenzoat) in E216 (propilparahidroksibenzoat), ki lahko povzročita alergijske reakcije (lahko zapoznele).
English: 6.1 List of excipients carmellose sodium (E466) sodium chloride sodium acetate glacial acetic acid (E260) methyl parahydroxybenzoate (methylparaben) (E218) propyl parahydroxybenzoate (propylparaben) (E216) metacresol lysine hydrochloride water for injections
Slovenian: 6.1 Seznam pomožnih snovi natrijev karmelozat (E466) natrijev klorid natrijev acetat koncentrirana ocetna kislina (ledocet) (E260) metilparahidroksibenzoat (metilparaben) (E218) propilparahidroksibenzoat (propilparaben) (E216) metakrezol lizinijev klorid voda za injekcije
English: • Do not use this medicine if you are breast-feeding.
Slovenian: • Zdravila REGRANEX ne smete uporabljati če dojite.
English: - Care should be taken during use to avoid microbial contamination and spoilage.
Slovenian: - Pazite tudi, da preprečite mikrobno kontaminacijo ali kvarjenje gela med njegovo uporabo.
English: Each gram of gel contains 100 μg of becaplermin*.
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA En gram gela vsebuje 100 μg bekaplermina*.
English: Do not apply any medicines to your ulcer while using REGRANEX, except for salt solution (saline) or water to clean the ulcer.
Slovenian: Med uporabo zdravila REGRANEX na razjedo ne smete nanašati drugih zdravil, razen fiziološke raztopine natrijevega klorida ali vode s katerima čistite razjedo.
English: - Any known malignancies (See section 4.4).
Slovenian: - Preobčutljivost za zdravilno učinkovino ali katerokoli pomožno snov, - kakršnekoli maligne novotvorbe (glejte poglavje 4.4), - pri bolnikih s klinično okuženimi ulkusi (glejte poglavje 4.4).
English: Contains carmellose sodium (E466), sodium chloride, sodium acetate, glacial acetic acid (E260), methyl parahydroxybenzoate (methylparaben) (E218), propyl parahydroxybenzoate (propylparaben) (E216), metacresol, lysine hydrochloride and water for injections.
Slovenian: Vsebuje natrijev karmelozat (E466), natrijev klorid, natrijev acetat, koncentrirano ocetno kislino (ledocet) (E260), metilparahidroksibenzoat (metilparaben) (E218), propil parahidroksibenzoat (propilparaben) (E216), metakrezol, lizinijev klorid in vodo za injekcije.
English: Wound infection should be treated prior to the use of REGRANEX.
Slovenian: Pred uporabo zdravila REGRANEX je treba okužbo rane pozdraviti.
English: • Do not use air- or water-tight (occlusive) dressings on the wound.
Slovenian: • Zdravila REGRANEX ne sme uporabljati skupaj s povojem, ki preprečuje stik rane z zrakom ali vodo (okluzivni povoj).
English: Adverse Drug Reactions Reported in Clinical Trials and Postmarketing Experience
Slovenian: Neželeni učinki o katerih so poročali v kliničnih preskušanjih in v redni klinični praksi Organski sistem Zelo pogosti
English: Applying REGRANEX
Slovenian: Nanos zdravila REGRANEX
English: Since there was no consistent increase in plasma platelet-derived growth factor-BB concentrations above pre-treatment concentrations, following 14 consecutive daily topical applications to ulcers in man, carcinogenesis and reproductive toxicity studies have not been conducted with REGRANEX.
Slovenian: Ker pri ljudeh po 14 dnevnem zaporednem nanašanju gela REGRANEX na razjede, ni bilo enotnih podatkov o povečanju plazemskih koncentracij rastnega dejavnika iz trombocitov-BB v primerjavi s koncentracijami pred zdravljenjem, študij kancerogenosti in vpliva na sposobnost razmnoževanja niso opravili.
English: • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
Slovenian: - Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
English: Becaplermin
Slovenian: Dojenje
English: The other ingredients are: carmellose sodium (E466), sodium chloride, sodium acetate, glacial acetic acid (E260), methyl parahydroxybenzoate (methylparaben) (E218), propyl parahydroxybenzoate (propylparaben) (E216), metacresol, lysine hydrochloride and water for injections.
Slovenian: - Pomožne snovi so: natrijev karmelozat (E466), natrijev klorid, natrijev acetat, koncentrirana ocetna kislina (ledocet) (E260), metilparahidroksibenzoat (metilparaben) (E218), propilparahidroksibenzoat (propilparaben) (E216), metakrezol, lizinijev klorid in voda za
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each gram of gel contains 100 μg of becaplermin
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN En gram gela vsebuje 100 μg bekaplermina
English: Before using REGRANEX
Slovenian: Pred uporabo zdravila REGRANEX:
English: Since there was no consistent increase in plasma platelet-derived growth factor-BB concentrations above pre-treatment concentrations, following 14 consecutive daily topical applications to ulcers, no untoward systemic events are expected.
Slovenian: Ker po 14 dnevnem zaporednem nanašanju gela REGRANEX na razjede, ni bilo enotnih podatkov o povečanju plazemskih koncentracij rastnega dejavnika iz trombocitov-BB v primerjavi s koncentracijami pred zdravljenjem, sistemskih neželenih učinkov ni pričakovati.
English: Do this before you apply REGRANEX
Slovenian: KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO REGRANEX
English: Pack size of 1.
Slovenian: 1 tuba v škatli.
English: Adverse Drug Reactions Frequency Category Common (≥1/100 to <1/10)
Slovenian: V skladu z dogovorom so neželeni učinki opredeljeni po pogostnosti kot: zelo pogosti (≥ 1/10),
English: Ask your doctor or pharmacist for advice before taking any medicine if you are pregnant or breastfeeding.
Slovenian: Posvetujte se z zdravnikom ali s farmacevtom, preden vzamete katerokoli zdravilo.
English: REGRANEX contains E218 (methyl parahydroxybenzoate) and E216 (propyl parahydroxybenzoate).
Slovenian: Zdravilo REGRANEX vsebuje E218 (metilparahidroksibenzoat) in E216 (propilparahidroksibenzoat), ki lahko povzročita alergijske reakcije (lahko zapoznele).
English: Contact your doctor immediately if you notice signs of infection of the ulcer (redness, swelling, fever, pain, or odour).
Slovenian: Če opazite znake okužbe razjede (pordelost, oteklina, zvišana telesna temperatura, bolečina ali neprijeten vonj), se nemudoma posvetujte s svojim zdravnikom, da vam predpiše ustrezno zdravljenje.
English: • Blisters and swelling under the skin
Slovenian: Redki • mehurčki na koži in otečeno podkožje.
English: • Burning sensation at the application site
Slovenian: Splošne težave in spremembe na mestu aplikacije edem
English: • Your doctor or healthcare professional treating any infection of the wound - treatment with
Slovenian: • zdravljenje okužbe razjede pri zdravniku- zdravljenje z zdravilom REGRANEX je treba prekiniti,
English: • Apply REGRANEX gel once a day using a clean cotton swab or wooden spatula.
Slovenian: • Zdravilo REGRANEX nanesite s kosmom vate ali leseno lopatko enkrat na dan. Tanko plast zdravila REGRANEX nanesite na celotno površino razjede.
English: • This medicine has been prescribed for you.
Slovenian: - Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
English: • Cover the ulcer with a moist saline (salt) gauze dressing.
Slovenian: • Razjedo prekrijte z obkladkom iz gaze, namočene v fiziološko raztopino.
English: See package leaflet for further information.
Slovenian: Za dodatne podatke, glejte navodilo za uporabo.
English: Malignancies distant from the site of application have occurred in becaplermin users in both clinical trial and in post-marketing use.
Slovenian: V kliničnih preskušanjih in uporabi po pridobitvi dovoljenja za promet so se pri bolnikih, ki so uporabljali bekaplermin pojavile maligne novotvorbe na mestih, ki niso bila v stiku z zdravilom.
English: JANSSEN-CILAG B.V. Tel: +31 13 583 73 73
Slovenian: Tel: +31 13 583 73 73
English: The effectiveness of Versican Plus DHPPi was initially investigated in a field study involving 129 dogs.
Slovenian: Učinkovitost cepiva Versican Plus DHPPi so najprej raziskali v terenski študiji, v katero so vključili 129 psov.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Versican Plus DHPPi on 4 July 2014.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Versican Plus DHPPi, veljavno po vsej Evropski uniji, izdala 4. julija 2014.
English: The percentage of dogs with protective levels of antibodies for parvovirus ranged from 73 to 100% and for parainfluenza virus 73 to 97%.
Slovenian: Zaščitne ravni protiteles proti parvovirusu je razvilo od 73 do 100 % psov, proti virusu parainfluence pa od 73 do 97 % psov.
English: Responses in puppies were lower than in adult dogs in some cases, because of antibodies inherited from their mothers since maternal antibodies may block the immune response to vaccination.
Slovenian: Odzivi pri pasjih mladičih so bili v določenih primerih slabši kot pri odraslih psih, kar je posledica protiteles, ki so jih podedovali od mater, saj lahko materina protitelesa zavrejo imunski odziv na cepivo.
English: Versican Plus DHPPi is used to protect dogs against:
Slovenian: Zdravilo Versican Plus DHPPi se uporablja za zaščito psov pred:
English: The most common side effect (seen in more than 1 in 100 dogs) with Versican Plus DHPPi is a short lived swelling of up to 5 cm which may occur at the injection site after vaccination.
Slovenian: Najpogostejši neželeni učinek cepiva Versican Plus DHPPi (opažen pri več kot 1 psu od 100) je kratkotrajna oteklina v velikosti do 5 cm, ki se lahko po cepljenju pojavi na mestu injiciranja.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Versican Plus DHPPi exceed the risks for the approved indications and recommended that Versican Plus DHPPi be given a marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je zaključil, da so koristi zdravila Versican Plus DHPPi večje od z njim povezanih tveganj, kadar se zdravilo uporablja za odobrene indikacije, in priporočil, da se zanj izda dovoljenje za promet.
English: The vaccine is given to puppies from six weeks of age as an injection under the skin which is repeated three to four weeks later.
Slovenian: Cepivo se daje pasjim mladičem, starejšim od šest tednov, z injiciranjem v podkožje, cepljenje pa je treba ponoviti tri do štiri tedne kasneje.
English: The benefit-risk balance may be found in the scientific discussion module of this EPAR.
Slovenian: Razmerje med koristmi in tveganji je na voljo v modulu o znanstveni razpravi tega evropskega javnega poročila o oceni zdravila.
English: When Versican Plus DHPPi is given to dogs, the animals' immune system recognises the viruses as ‘foreign' and makes antibodies against them.
Slovenian: Ko psi prejmejo cepivo Versican Plus DHPPi, imunski sistem živali viruse in bakterije prepozna kot „tujke“ ter začne proti njim tvoriti protitelesa.
English: Versican Plus DHPPi is a vaccine.
Slovenian: Zdravilo Versican Plus DHPPi je cepivo.
English: Annual revaccination is required for protection against canine parainfluenza virus.
Slovenian: Za zaščito pred virusom pasje parainfluence je ponovno cepljenje potrebno vsako leto.
English: What benefit has Versican Plus DHPPi shown during the studies?
Slovenian: Kakšne koristi je zdravilo Versican Plus DHPPi izkazalo med študijami?
English: Versican Plus DHPPi is available as a lyophilisate (freeze-dried pellet) with a solvent that are made up into a suspension for injection.
Slovenian: Zdravilo Versican Plus DHPPi je na voljo v obliki liofilizata (pelet, posušenih v zamrznjenem stanju) in vehikla za pripravo suspenzije za injiciranje.
English: • canine parainfluenza virus and canine adenovirus type 2, which cause kennel cough.
Slovenian: • virusom pasje parainfluence in pasjim adenovirusom tipa 2, ki povzročata kužni kašelj.
English: Other information about Versican Plus DHPPi:
Slovenian: Druge informacije o zdravilu Versican Plus DHPPi:
English: The field study showed that vaccination with Versican Plus DHPPi resulted in levels of antibodies that were sufficient to protect against canine distemper virus and canine adenovirus in all dogs.
Slovenian: Terenska študija je pokazala, da so bile po cepljenju s cepivom Versican Plus DHPPi ravni protiteles pri vseh psih dovolj visoke za zaščito pred virusom pasje kuge in pasjim adenovirusom.
English: Versican Plus DHPPi is a veterinary vaccine that contains live attenuated (weakened) canine distemper virus, canine adenovirus type 2, canine parvovirus type 2b and canine parainfluenza virus type 2.
Slovenian: Zdravilo Versican Plus DHPPi je cepivo za uporabo v veterinarski medicini, ki vsebuje živ atenuiran (oslabljen) virus pasje kuge, pasji adenovirus tipa 2, pasji parvovirus tipa 2b in virus pasje parainfluence tipa 2.
English: What is the risk associated with Versican Plus DHPPi?
Slovenian: Kakšna tveganja so povezana z zdravilom Versican Plus DHPPi?
English: This will help protect them against distemper, adenovirus liver infection, parvovirosis and kennel cough.
Slovenian: To pomaga zaščititi pse pred kugo, okužbo jeter z adenovirusom, parvovirozo in kužnim kašljem.
English: Why has Versican Plus DHPPi been approved?
Slovenian: Zakaj je bilo zdravilo Versican Plus DHPPi odobreno?
English: The field study involved the larger vaccine combinations Versican Plus DHPPi/L4 and Versican Plus DHPPi/L4R, which are also intended to protect against distemper, adenovirus, parvovirosis and kennel cough in addition to other diseases to demonstrate effectiveness of Versican Plus DHPPi.
Slovenian: Da bi dokazali učinkovitost cepiva Versican Plus DHPPi, je terenska študija vključevala tudi cepivi s širšo kombinacijo učinkovin, in sicer cepivo Versican Plus DHPPi/L4 in cepivo Versican Plus DHPPi/L4R, ki pse zaščitita pred pasjo kugo, adenovirusom, parvovirozo in kužnim kašljem ter nekaterimi drugimi boleznimi.
English: What is Versican Plus DHPPi?
Slovenian: Kaj je zdravilo Versican Plus DHPPi?